NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

HealthInvest Partners AB's Holding History (CIK: 0001381843)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 197,036 Value ($000) $6,912 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 193,625 Value ($000) $585 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 157,223 Value ($000) $2,847 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 107,783 Value ($000) $2,206 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 138,983 Value ($000) $3,558 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 138,983 Value ($000) $2,307 Avg Close $17.30 Range $15.19 - $21.48

Q2 2024

Shares 75,794 Value ($000) $1,456 Avg Close $20.06 Range $16.62 - $24.79

Q1 2024

Shares 22,394 Value ($000) $530 Avg Close $20.30 Range $11.18 - $26.35

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	197,036	$6,912	$36.39	$28.19 - $42.00
Q3 2025	193,625	$585	$23.97	$17.97 - $28.91
Q2 2025	157,223	$2,847	$18.24	$14.06 - $22.25
Q1 2025	107,783	$2,206	$22.23	$17.18 - $26.80
Q4 2024	138,983	$3,558	$21.24	$15.51 - $27.29
Q3 2024	138,983	$2,307	$17.30	$15.19 - $21.48
Q2 2024	75,794	$1,456	$20.06	$16.62 - $24.79
Q1 2024	22,394	$530	$20.30	$11.18 - $26.35